Prevalence of anti-hepatitis C virus antibodies and hepatitis C virus viraemia in chronic haemodialysis patients in Libya.
Elzouki
A N
AN
Department of Medicine, University of Lund, Malmö University Hospital, Sweden.
Bushala
M
M
Tobji
R S
RS
Khfaifi
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification*; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000453:epidemiology* / Q000517:prevention & control; D018937:Hepatitis C Antibodies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008002:Libya / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D014766:Viremia / Q000453:epidemiology* / Q000517:prevention & control
D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies